Listed

Abbott Laboratories

ABTNYSECIK 1800HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$11.16bn, Q1 FY2026
Operating income$1.34bn, Q1 FY2026
Net income$1.08bn, Q1 FY2026
Abbott Laboratories, income statement, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31
Revenue$bn10.0Revenue, Q2 FY2023, three months to 2023-06-30$9.98bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure10.1Revenue, Q3 FY2023, three months to 2023-09-30$10.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure10.2Revenue, Q4 FY2023, three months to 2023-12-31$10.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure10.0Revenue, Q1 FY2024, three months to 2024-03-31$9.96bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure10.4Revenue, Q2 FY2024, three months to 2024-06-30$10.38bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure10.6Revenue, Q3 FY2024, three months to 2024-09-30$10.63bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure11.0Revenue, Q4 FY2024, three months to 2024-12-31$10.97bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure10.4Revenue, Q1 FY2025, three months to 2025-03-31$10.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure11.1Revenue, Q2 FY2025, three months to 2025-06-30$11.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure11.4Revenue, Q3 FY2025, three months to 2025-09-30$11.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure11.5Revenue, Q4 FY2025, three months to 2025-12-31$11.46bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure11.2Revenue, Q1 FY2026, three months to 2026-03-31$11.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Cost of revenue$bn4.5Cost of revenue, Q2 FY2023, three months to 2023-06-30$4.48bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure4.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$4.61bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure4.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$4.56bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure4.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$4.46bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure4.6Cost of revenue, Q2 FY2024, three months to 2024-06-30$4.60bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure4.7Cost of revenue, Q3 FY2024, three months to 2024-09-30$4.70bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure4.9Cost of revenue, Q4 FY2024, three months to 2024-12-31$4.94bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure4.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.47bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure4.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$4.85bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure5.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$5.08bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure4.9Cost of revenue, Q4 FY2025, three months to 2025-12-31$4.92bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure4.9Cost of revenue, Q1 FY2026, three months to 2026-03-31$4.89bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Gross profit$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$bn0.7Research and development, Q2 FY2023, three months to 2023-06-30$715.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure0.7Research and development, Q3 FY2023, three months to 2023-09-30$672.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure0.7Research and development, Q4 FY2023, three months to 2023-12-31$700.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.7Research and development, Q1 FY2024, three months to 2024-03-31$684.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure0.7Research and development, Q2 FY2024, three months to 2024-06-30$698.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.7Research and development, Q3 FY2024, three months to 2024-09-30$713.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure0.7Research and development, Q4 FY2024, three months to 2024-12-31$749.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.7Research and development, Q1 FY2025, three months to 2025-03-31$716.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure0.7Research and development, Q2 FY2025, three months to 2025-06-30$725.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.8Research and development, Q3 FY2025, three months to 2025-09-30$766.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure0.7Research and development, Q4 FY2025, three months to 2025-12-31$735.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.8Research and development, Q1 FY2026, three months to 2026-03-31$767.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Selling, general and administrative$bn2.7Selling, general and administrative, Q2 FY2023, three months to 2023-06-30$2.74bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure2.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$2.72bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure2.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$2.72bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure3.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$2.96bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure2.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$2.94bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure2.9Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$2.90bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure2.9Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$2.91bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure3.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$3.06bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure3.1Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$3.09bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure3.1Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$3.05bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure3.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$3.13bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure3.7Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$3.74bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Operating income$bn1.5Operating income, Q2 FY2023, three months to 2023-06-30$1.54bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure1.6Operating income, Q3 FY2023, three months to 2023-09-30$1.65bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure1.8Operating income, Q4 FY2023, three months to 2023-12-31$1.78bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1.4Operating income, Q1 FY2024, three months to 2024-03-31$1.39bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure1.7Operating income, Q2 FY2024, three months to 2024-06-30$1.67bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure1.9Operating income, Q3 FY2024, three months to 2024-09-30$1.86bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure1.9Operating income, Q4 FY2024, three months to 2024-12-31$1.91bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1.7Operating income, Q1 FY2025, three months to 2025-03-31$1.69bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure2.1Operating income, Q2 FY2025, three months to 2025-06-30$2.05bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure2.1Operating income, Q3 FY2025, three months to 2025-09-30$2.06bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure2.3Operating income, Q4 FY2025, three months to 2025-12-31$2.25bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1.3Operating income, Q1 FY2026, three months to 2026-03-31$1.34bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Interest expense$bn0.2Interest expense, Q2 FY2023, three months to 2023-06-30$159.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure0.2Interest expense, Q3 FY2023, three months to 2023-09-30$166.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure0.2Interest expense, Q4 FY2023, three months to 2023-12-31$159.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-16, accession 0001628280-24-005348. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-31$141.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-30$140.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-09-30$142.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$136.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2025-03-31$131.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure0.1Interest expense, Q2 FY2025, three months to 2025-06-30$121.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.1Interest expense, Q3 FY2025, three months to 2025-09-30$121.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure0.1Interest expense, Q4 FY2025, three months to 2025-12-31$120.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.2Interest expense, Q1 FY2026, three months to 2026-03-31$174.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Income tax$bn0.3Income tax, Q2 FY2023, three months to 2023-06-30$261.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure0.2Income tax, Q3 FY2023, three months to 2023-09-30$235.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure0.2Income tax, Q4 FY2023, three months to 2023-12-31$201.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$211.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure0.3Income tax, Q2 FY2024, three months to 2024-06-30$305.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.3Income tax, Q3 FY2024, three months to 2024-09-30$294.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure(7.2)Income tax, Q4 FY2024, three months to 2024-12-31−$7.20bn. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.5Income tax, Q1 FY2025, three months to 2025-03-31$453.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure0.4Income tax, Q2 FY2025, three months to 2025-06-30$371.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.5Income tax, Q3 FY2025, three months to 2025-09-30$536.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure0.6Income tax, Q4 FY2025, three months to 2025-12-31$582.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2026, three months to 2026-03-31$372.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Net income$bn1.4Net income, Q2 FY2023, three months to 2023-06-30$1.38bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure1.4Net income, Q3 FY2023, three months to 2023-09-30$1.44bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure1.6Net income, Q4 FY2023, three months to 2023-12-31$1.59bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1.2Net income, Q1 FY2024, three months to 2024-03-31$1.23bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure1.3Net income, Q2 FY2024, three months to 2024-06-30$1.30bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure1.6Net income, Q3 FY2024, three months to 2024-09-30$1.65bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure9.2Net income, Q4 FY2024, three months to 2024-12-31$9.23bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1.3Net income, Q1 FY2025, three months to 2025-03-31$1.32bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure1.8Net income, Q2 FY2025, three months to 2025-06-30$1.78bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure1.6Net income, Q3 FY2025, three months to 2025-09-30$1.64bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure1.8Net income, Q4 FY2025, three months to 2025-12-31$1.78bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1.1Net income, Q1 FY2026, three months to 2026-03-31$1.08bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Diluted EPS$ per share0.78Diluted EPS, Q2 FY2023, three months to 2023-06-30$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure0.82Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figurenot reported0.70Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure0.74Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.94Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figurenot reported0.76Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure1.01Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.94Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figurenot reported0.61Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Basic EPS$ per share0.79Basic EPS, Q2 FY2023, three months to 2023-06-30$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure0.82Basic EPS, Q3 FY2023, three months to 2023-09-30$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figurenot reported0.70Basic EPS, Q1 FY2024, three months to 2024-03-31$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure0.74Basic EPS, Q2 FY2024, three months to 2024-06-30$0.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.94Basic EPS, Q3 FY2024, three months to 2024-09-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figurenot reported0.76Basic EPS, Q1 FY2025, three months to 2025-03-31$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure1.02Basic EPS, Q2 FY2025, three months to 2025-06-30$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure0.94Basic EPS, Q3 FY2025, three months to 2025-09-30$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figurenot reported0.62Basic EPS, Q1 FY2026, three months to 2026-03-31$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure

Balance sheet

Cash and equivalents$6.80bn, Q1 FY2026
Long-term debt$29.64bn, Q1 FY2026
Shareholders' equity$52.06bn, Q1 FY2026
Abbott Laboratories, balance sheet, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31
Cash and equivalents$bn7.8Cash and equivalents, Q2 FY2023, at 2023-06-30$7.83bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure6.7Cash and equivalents, Q3 FY2023, at 2023-09-30$6.71bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure6.9Cash and equivalents, FY2023, at 2023-12-31$6.90bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure6.3Cash and equivalents, Q1 FY2024, at 2024-03-31$6.28bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure7.0Cash and equivalents, Q2 FY2024, at 2024-06-30$6.99bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure7.6Cash and equivalents, Q3 FY2024, at 2024-09-30$7.56bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure7.6Cash and equivalents, FY2024, at 2024-12-31$7.62bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure6.5Cash and equivalents, Q1 FY2025, at 2025-03-31$6.53bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure7.0Cash and equivalents, Q2 FY2025, at 2025-06-30$6.95bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure7.5Cash and equivalents, Q3 FY2025, at 2025-09-30$7.51bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure8.5Cash and equivalents, FY2025, at 2025-12-31$8.52bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure6.8Cash and equivalents, Q1 FY2026, at 2026-03-31$6.80bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Current assets$bn23.5Current assets, Q2 FY2023, at 2023-06-30$23.50bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure22.7Current assets, Q3 FY2023, at 2023-09-30$22.66bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure22.7Current assets, FY2023, at 2023-12-31$22.67bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure22.4Current assets, Q1 FY2024, at 2024-03-31$22.38bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure23.1Current assets, Q2 FY2024, at 2024-06-30$23.12bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure23.8Current assets, Q3 FY2024, at 2024-09-30$23.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure23.7Current assets, FY2024, at 2024-12-31$23.66bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure23.2Current assets, Q1 FY2025, at 2025-03-31$23.15bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure24.5Current assets, Q2 FY2025, at 2025-06-30$24.47bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure24.8Current assets, Q3 FY2025, at 2025-09-30$24.84bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure26.0Current assets, FY2025, at 2025-12-31$26.00bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure25.5Current assets, Q1 FY2026, at 2026-03-31$25.51bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Total assets$bn73.4Total assets, Q2 FY2023, at 2023-06-30$73.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure72.1Total assets, Q3 FY2023, at 2023-09-30$72.09bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure73.2Total assets, FY2023, at 2023-12-31$73.21bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure72.5Total assets, Q1 FY2024, at 2024-03-31$72.47bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure73.0Total assets, Q2 FY2024, at 2024-06-30$73.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure74.4Total assets, Q3 FY2024, at 2024-09-30$74.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure81.4Total assets, FY2024, at 2024-12-31$81.41bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure81.4Total assets, Q1 FY2025, at 2025-03-31$81.45bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure84.0Total assets, Q2 FY2025, at 2025-06-30$84.00bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure84.2Total assets, Q3 FY2025, at 2025-09-30$84.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure86.7Total assets, FY2025, at 2025-12-31$86.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure110Total assets, Q1 FY2026, at 2026-03-31$110.43bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Current liabilities$bn14.4Current liabilities, Q2 FY2023, at 2023-06-30$14.35bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure13.0Current liabilities, Q3 FY2023, at 2023-09-30$13.04bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure13.8Current liabilities, FY2023, at 2023-12-31$13.84bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure14.0Current liabilities, Q1 FY2024, at 2024-03-31$14.02bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure13.8Current liabilities, Q2 FY2024, at 2024-06-30$13.76bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure14.9Current liabilities, Q3 FY2024, at 2024-09-30$14.90bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure14.2Current liabilities, FY2024, at 2024-12-31$14.16bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure13.0Current liabilities, Q1 FY2025, at 2025-03-31$13.00bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure13.4Current liabilities, Q2 FY2025, at 2025-06-30$13.44bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure14.6Current liabilities, Q3 FY2025, at 2025-09-30$14.58bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure16.5Current liabilities, FY2025, at 2025-12-31$16.50bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure18.4Current liabilities, Q1 FY2026, at 2026-03-31$18.38bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Long-term debt$bn14.6Long-term debt, Q2 FY2023, at 2023-06-30$14.56bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure14.5Long-term debt, Q3 FY2023, at 2023-09-30$14.48bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure13.6Long-term debt, FY2023, at 2023-12-31$13.60bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure12.6Long-term debt, Q1 FY2024, at 2024-03-31$12.58bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure13.1Long-term debt, Q2 FY2024, at 2024-06-30$13.14bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure12.8Long-term debt, Q3 FY2024, at 2024-09-30$12.82bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure12.6Long-term debt, FY2024, at 2024-12-31$12.63bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure12.7Long-term debt, Q1 FY2025, at 2025-03-31$12.74bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure12.9Long-term debt, Q2 FY2025, at 2025-06-30$12.93bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure11.6Long-term debt, Q3 FY2025, at 2025-09-30$11.60bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure9.9Long-term debt, FY2025, at 2025-12-31$9.90bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure29.6Long-term debt, Q1 FY2026, at 2026-03-31$29.64bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Current portion of debt$bn2.3Current portion of debt, Q2 FY2023, at 2023-06-30$2.28bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure1.1Current portion of debt, Q3 FY2023, at 2023-09-30$1.05bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure1.1Current portion of debt, FY2023, at 2023-12-31$1.08bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure2.0Current portion of debt, Q1 FY2024, at 2024-03-31$2.01bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure1.6Current portion of debt, Q2 FY2024, at 2024-06-30$1.61bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure2.2Current portion of debt, Q3 FY2024, at 2024-09-30$2.15bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure1.5Current portion of debt, FY2024, at 2024-12-31$1.50bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure0.5Current portion of debt, Q1 FY2025, at 2025-03-31$506.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure0.5Current portion of debt, Q2 FY2025, at 2025-06-30$507.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure1.3Current portion of debt, Q3 FY2025, at 2025-09-30$1.34bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure3.0Current portion of debt, FY2025, at 2025-12-31$3.03bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure4.4Current portion of debt, Q1 FY2026, at 2026-03-31$4.41bn. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Short-term borrowings$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$bn37.2Shareholders' equity, Q2 FY2023, at 2023-06-30$37.17bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure37.5Shareholders' equity, Q3 FY2023, at 2023-09-30$37.48bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure38.6Shareholders' equity, FY2023, at 2023-12-31$38.60bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-21, accession 0001628280-25-007110.Report this figure38.8Shareholders' equity, Q1 FY2024, at 2024-03-31$38.81bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure39.3Shareholders' equity, Q2 FY2024, at 2024-06-30$39.32bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure39.8Shareholders' equity, Q3 FY2024, at 2024-09-30$39.80bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure47.7Shareholders' equity, FY2024, at 2024-12-31$47.66bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-20, accession 0001628280-26-010185.Report this figure48.8Shareholders' equity, Q1 FY2025, at 2025-03-31$48.81bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure50.6Shareholders' equity, Q2 FY2025, at 2025-06-30$50.56bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure51.0Shareholders' equity, Q3 FY2025, at 2025-09-30$50.95bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure52.1Shareholders' equity, FY2025, at 2025-12-31$52.13bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure52.1Shareholders' equity, Q1 FY2026, at 2026-03-31$52.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure

Cash flow

Operating cash flow$1.31bn, Q1 FY2026
Capital expenditure$399.0m, Q1 FY2026
Share repurchases$180.0m, Q1 FY2026
Abbott Laboratories, cash flow, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31
Operating cash flow$m1,203Operating cash flow, Q2 FY2023, three months to 2023-06-30$1.20bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-07-31, accession 0001628280-24-033740. Derived: 6-month figure less the 3-month figure.Report this figure1,877Operating cash flow, Q3 FY2023, three months to 2023-09-30$1.88bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001628280-24-044602. Derived: 9-month figure less the 6-month figure.Report this figure3,038Operating cash flow, Q4 FY2023, three months to 2023-12-31$3.04bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1,025Operating cash flow, Q1 FY2024, three months to 2024-03-31$1.02bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure1,960Operating cash flow, Q2 FY2024, three months to 2024-06-30$1.96bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure2,705Operating cash flow, Q3 FY2024, three months to 2024-09-30$2.71bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure2,868Operating cash flow, Q4 FY2024, three months to 2024-12-31$2.87bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1,417Operating cash flow, Q1 FY2025, three months to 2025-03-31$1.42bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure2,047Operating cash flow, Q2 FY2025, three months to 2025-06-30$2.05bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure2,787Operating cash flow, Q3 FY2025, three months to 2025-09-30$2.79bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure3,315Operating cash flow, Q4 FY2025, three months to 2025-12-31$3.31bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1,315Operating cash flow, Q1 FY2026, three months to 2026-03-31$1.31bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Capital expenditure$m507Capital expenditure, Q2 FY2023, three months to 2023-06-30$507.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-07-31, accession 0001628280-24-033740. Derived: 6-month figure less the 3-month figure.Report this figure560Capital expenditure, Q3 FY2023, three months to 2023-09-30$560.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-31, accession 0001628280-24-044602. Derived: 9-month figure less the 6-month figure.Report this figure755Capital expenditure, Q4 FY2023, three months to 2023-12-31$755.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure398Capital expenditure, Q1 FY2024, three months to 2024-03-31$398.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure533Capital expenditure, Q2 FY2024, three months to 2024-06-30$533.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure556Capital expenditure, Q3 FY2024, three months to 2024-09-30$556.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure720Capital expenditure, Q4 FY2024, three months to 2024-12-31$720.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure484Capital expenditure, Q1 FY2025, three months to 2025-03-31$484.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure502Capital expenditure, Q2 FY2025, three months to 2025-06-30$502.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure496Capital expenditure, Q3 FY2025, three months to 2025-09-30$496.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure689Capital expenditure, Q4 FY2025, three months to 2025-12-31$689.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure399Capital expenditure, Q1 FY2026, three months to 2026-03-31$399.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Dividends paid$m890Dividends paid, Q2 FY2023, three months to 2023-06-30$890.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2024-07-31, accession 0001628280-24-033740. Derived: 6-month figure less the 3-month figure.Report this figure888Dividends paid, Q3 FY2023, three months to 2023-09-30$888.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2024-10-31, accession 0001628280-24-044602. Derived: 9-month figure less the 6-month figure.Report this figure888Dividends paid, Q4 FY2023, three months to 2023-12-31$888.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure957Dividends paid, Q1 FY2024, three months to 2024-03-31$957.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure961Dividends paid, Q2 FY2024, three months to 2024-06-30$961.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure960Dividends paid, Q3 FY2024, three months to 2024-09-30$960.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure958Dividends paid, Q4 FY2024, three months to 2024-12-31$958.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1,026Dividends paid, Q1 FY2025, three months to 2025-03-31$1.03bn. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure1,029Dividends paid, Q2 FY2025, three months to 2025-06-30$1.03bn. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure1,031Dividends paid, Q3 FY2025, three months to 2025-09-30$1.03bn. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure1,030Dividends paid, Q4 FY2025, three months to 2025-12-31$1.03bn. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure1,098Dividends paid, Q1 FY2026, three months to 2026-03-31$1.10bn. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure
Share repurchases$m426Share repurchases, Q2 FY2023, three months to 2023-06-30$426.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-07-31, accession 0001628280-24-033740. Derived: 6-month figure less the 3-month figure.Report this figure2.0Share repurchases, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-31, accession 0001628280-24-044602. Derived: 9-month figure less the 6-month figure.Report this figure259Share repurchases, Q4 FY2023, three months to 2023-12-31$259.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure226Share repurchases, Q1 FY2024, three months to 2024-03-31$226.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure3.0Share repurchases, Q2 FY2024, three months to 2024-06-30$3.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure751Share repurchases, Q3 FY2024, three months to 2024-09-30$751.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure315Share repurchases, Q4 FY2024, three months to 2024-12-31$315.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure280Share repurchases, Q1 FY2025, three months to 2025-03-31$280.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure6.0Share repurchases, Q2 FY2025, three months to 2025-06-30$6.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-30, accession 0001628280-25-036720. Derived: 6-month figure less the 3-month figure.Report this figure305Share repurchases, Q3 FY2025, three months to 2025-09-30$305.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-29, accession 0001628280-25-047131. Derived: 9-month figure less the 6-month figure.Report this figure302Share repurchases, Q4 FY2025, three months to 2025-12-31$302.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-20, accession 0001628280-26-010185. Derived: 12-month figure less the 9-month figure.Report this figure180Share repurchases, Q1 FY2026, three months to 2026-03-31$180.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure

Shares

Diluted shares (weighted)1.75bn, Q1 FY2026
Abbott Laboratories, shares, quarterly
Line itemUnitQ2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31
Diluted shares (weighted)m shares1,765Diluted shares (weighted), Q2 FY2022, three months to 2022-06-301,765,463,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-03, accession 0001628280-23-027203.Report this figure1,764Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,763,653,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0001628280-23-035957.Report this figure1,752Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,751,715,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001628280-24-020011.Report this figure1,750Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,750,248,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-31, accession 0001628280-24-033740.Report this figure1,748Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,748,289,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001628280-24-044602.Report this figure1,750Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,749,652,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-30, accession 0001628280-25-021090.Report this figure1,751Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,751,153,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure1,748Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,747,597,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure1,747Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,747,220,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure1,751Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,750,835,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001628280-25-036720.Report this figure1,749Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,749,361,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001628280-25-047131.Report this figure1,747Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,747,073,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure

Shares outstanding: 1.74bnShares outstanding, Q1 FY2026, at 2026-03-311,741,812,429 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-04-29, accession 0001628280-26-028357.Report this figure at Mar 31, 2026, from the cover of the 10-Q filed Apr 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. Listed shows no prices and gives no investment advice.